Close Menu

NEW YORK – Luminex Corporation announced Tuesday it has received $642,450 from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority to help develop the company's Aries SARS-CoV-2 Assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.